Pharma Reviews: Glenmark sells gynac business for Rs 115 crore
Rating agency CRISIL has said the woes of Indian generic companies are likely to continue as the regulatory action by the US Food and Drug ...
Read more: Glenmark sells gynac business for Rs 115 crore